Compare BLCO & OUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLCO | OUT |
|---|---|---|
| Founded | 1853 | 2013 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 5.1B |
| IPO Year | 2022 | 2013 |
| Metric | BLCO | OUT |
|---|---|---|
| Price | $17.41 | $31.24 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 7 |
| Target Price | $19.39 | ★ $38.00 |
| AVG Volume (30 Days) | 485.4K | ★ 1.2M |
| Earning Date | 10-28-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 4.20% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.54 |
| Revenue | ★ $5,101,000,000.00 | $1,831,700,000.00 |
| Revenue This Year | $7.68 | $9.12 |
| Revenue Next Year | $5.95 | $2.68 |
| P/E Ratio | ★ N/A | $58.14 |
| Revenue Growth | ★ 6.47 | 0.04 |
| 52 Week Low | $14.44 | $16.97 |
| 52 Week High | $18.92 | $34.96 |
| Indicator | BLCO | OUT |
|---|---|---|
| Relative Strength Index (RSI) | 56.37 | 67.16 |
| Support Level | $16.71 | $31.11 |
| Resistance Level | $17.54 | $33.71 |
| Average True Range (ATR) | 0.52 | 0.61 |
| MACD | 0.09 | 0.23 |
| Stochastic Oscillator | 93.60 | 87.43 |
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Outfront Media Inc is a real estate investment trust involved in the ownership of advertising space on its portfolio of billboards and transit displays. The company has two reportable operating segments: Billboard and Transit. It derives maximum revenue from Billboard Segment. The company geographically operates in United States and Canada, of which United States derive maximum revenue.